内部人交易记录
其他基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Devroe Eric. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €16k. History available since 14 November 2022. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Devroe Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
604 股@ US$2.01Common StockSEC:0000905148-26-003837:0
723 股@ US$1.631.5% 占其流量Common StockSEC:0000905148-26-000935:0
10,000 股@ US$1.721821.8% 占其流量Common StockSEC:0000905148-26-000212:0
613 股@ US$2.242.3% 占其流量Common StockSEC:0000905148-25-004128:0
613 股@ US$1.391.4% 占其流量Common StockSEC:0000905148-25-003040:0
613 股@ US$1.141.2% 占其流量Common StockSEC:0000905148-25-001821:0
724 股@ US$5.427.3% 占其流量Common StockSEC:0000905148-25-000726:0
613 股@ US$7.929.0% 占其流量Common StockSEC:0000905148-24-003224:0
613 股@ US$7.027.6% 占其流量Common StockSEC:0000905148-24-002278:0
10,000 股@ US$1.0418.7% 占其流量Common StockSEC:0000905148-24-001566:0
613 股@ US$8.369.2% 占其流量Common StockSEC:0000905148-24-001485:0
723 股@ US$3.404.5% 占其流量Common StockSEC:0000905148-24-000761:0
2,450 股@ US$5.0822.7% 占其流量Common StockSEC:0000905148-23-001473:0
9,225 股@ US$1.0417.5% 占其流量Common StockSEC:0001140361-23-028539:0
33,383 股0Common StockSEC:0001209191-22-057399:0
About Devroe Eric
Devroe Eric is Chief Operating Officer at Acrivon Therapeutics, Inc. (XNAS). He has 14 filings in total, and across the recent filings tracked, buys amount to EUR 14758 and sells to EUR 0, over the period from 2022-11-16 to 2026-02-18, with Retenue fiscale as the most frequent transaction nature.